Clinical Trial Update: REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 clinical trial assessing reirradiation with a PD-1 inhibitor in patients with recurrent head and neck squamo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Oslo University Hospital | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED